Current Controlled Trials - Search the ISRCTN Register of Clinical Trials.

Welcome

12 February 2012

	Trial registration
	Unique identification scheme
	International databases

Find trials

ISRCTN Register

Registration

New application

Updating record

Information

introduction

governing board

ISRCTN FAQs

data set

guidance notes

International Standard Randomised Controlled Trial Number Register

Showing records: 6731 to 6740 of 10349

SEARCH FOR	RESULTS ORDER	DIRECTION	MAX RESULTS

6731	A double blind, randomised placebo controlled study of the safety, reactogenicity and immunogenicity of two doses of orally administered human rotavirus vaccine (RIX4414) in healthy infants in South Africa
	ISRCTN:	ISRCTN37373664
	Sponsor:	World Health Organization (WHO)/Department of Immunisation, Vaccines and Biologicals (IVB) (Switzerland)
	Date assigned:	25 November 2005

6732	A phase II, double-blind, randomised, placebo-controlled study to assess the safety, reactogenicity and immunogenicity of three doses of GlaxoSmithKline (GSK) Biologicals� oral live attenuated human rotavirus (HRV) vaccine (RIX4414 at 106.5 CCID50) administered to human immunodeficiency virus (HIV) infected infants at 6, 10 and 14 weeks of age in South Africa
	ISRCTN:	ISRCTN11877362
	Sponsor:	World Health Organization (WHO)/Department of Immunisation, Vaccines and Biologicals (IVB) (Switzerland)
	Date assigned:	25 November 2005

6733	Study of safety and immunogenicity of Measles vaccine (Rouvax®) administered by transcutaneous route (France)
	ISRCTN:	ISRCTN88861431
	Sponsor:	World Health Organization (WHO)/Department of Immunisation, Vaccines and Biologicals (IVB) (Switzerland)
	Date assigned:	25 November 2005

6734	A prospective randomised controlled trial of Vypro II and TiMesh in inguinal hernia repair using the total extraperitoneal endoscopic approach
	ISRCTN:	ISRCTN96288558
	Sponsor:	Spital Limmattal, Department of Surgery (Switzerland)
	Date assigned:	24 November 2005

6735	Warning Time and Patient Centred Goals with Transdermal Oxybutynin
	ISRCTN:	ISRCTN87161129
	Sponsor:	King's College London (UK)
	Date assigned:	24 November 2005

6736	Open, randomised phase III study assessing the toxicity and efficacy of platinum-based chemotherapy with vitamin supplementation in the treatment of lung cancer
	ISRCTN:	ISRCTN87343655
	Sponsor:	Royal Marsden Hospital (UK)
	Date assigned:	24 November 2005

6737	Therapeutic vaccination for chronic hepatitis B virus infection in Africa
	ISRCTN:	ISRCTN67270384
	Sponsor:	University of Oxford (UK)
	Date assigned:	23 November 2005

6738	Melioidosis ERadication THerapy/THailand
	ISRCTN:	ISRCTN86140460
	Sponsor:	Khon Kaen University (Thailand)
	Date assigned:	23 November 2005

6739	The utility of pre-assessment standardised diagnosis in child and adolescent mental health services
	ISRCTN:	ISRCTN31394658
	Sponsor:	King's College London (UK)
	Date assigned:	23 November 2005

6740	Randomised controlled trial to compare the effects of granulocyte-colony stimulating factor (G-CSF) and autologous bone marrow progenitor cells infusion on quality of life and left ventricular function in patients with heart failure secondary to ischaemic heart disease
	ISRCTN:	ISRCTN68837678
	Sponsor:	Barts and the London NHS Trust (UK)
	Date assigned:	23 November 2005

RESULT PAGE

674


© 2012 ISRCTN unless otherwise stated.